De-Sheng Wang (De-Shen Wang, Rui-Hua Xu, Deshen Wang)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Patients Undergoing

Prognostic Factors

Top Venues

Therapeutic advances in medical oncology

NPJ precision oncology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zhi-Gang Chen, Xiao-Meng Ji, Yu-Xia Xu, William Pat Fong, Xiao-Yun Liu, Jie-Ying Liang, Qiong Tan, Lei Wen, Yan-Yu Cai, De-Sheng Wang, Yu-Hong Li
Methylated ctDNA predicts early recurrence risk in patients undergoing resection of initially unresectable colorectal cancer liver metastases. Therapeutic advances in medical oncology 16 (2024)
Zi-Jing Li, William Pat Fong, Dong-Sheng Zhang, Hui-Yan Luo, Dong-Liang Chen, Yan-Yu Cai, Zhi-Gang Chen, Jian-Li Duan, Zi-Yao Huang, Yu-Ting Lu, Xiao-Xia Huang, Yu-Hong Li, De-Sheng Wang
Exploring ALK fusion in colorectal cancer: a case series and comprehensive analysis. NPJ precision oncology 8 (1) (2024)
Zi-Jing Li, William Pat Fong, Dong-Sheng Zhang, Hui-Yan Luo, Dong-Liang Chen, Yan-Yu Cai, Zhi-Gang Chen, Jian-Li Duan, Zi-Yao Huang, Yu-Ting Lu, Xiao-Xia Huang, Yu-Hong Li, De-Sheng Wang
Exploring ALK fusion in colorectal cancer: a case series and comprehensive analysis. NPJ precision oncology 8 (1) (2024)
De-Sheng Wang, Chao Ren, Shan-Shan Li, William Pat Fong, Xiao-Jun Wu, Jian Xiao, Bin-Kui Li, Yun Zheng, Pei-Rong Ding, Gong Chen, Miao-Zhen Qiu, Zhi-Qiang Wang, Feng-Hua Wang, Hui-Yan Luo, Feng Wang, Xiao-Zhong Wang, Ling-Yun Wang, De-Jin Xie, Tao Chen, Li-Ren Li, Zhen-Hai Lu, Xiao-Hui Zhai, Tian-Shu Liu, Ying Yuan, Jia-Qi Chen, Qiong Tan, Zhi-Zhong Pan, De-Sen Wan, Rong Zhang, Yun-Fei Yuan, Rui-Hua Xu, Yu-Hong Li
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial. PLoS medicine 21 (5) (2024)
Zi-Jing Li, William Pat Fong, Dong-Sheng Zhang, Hui-Yan Luo, Dong-Liang Chen, Yan-Yu Cai, Zhi-Gang Chen, Jian-Li Duan, Zi-Yao Huang, Yu-Ting Lu, Xiao-Xia Huang, Yu-Hong Li, De-Sheng Wang
Exploring ALK fusion in colorectal cancer: a case series and comprehensive analysis. NPJ precision oncology 8 (1) (2024)
De-Sheng Wang, Chao Ren, Shan-Shan Li, William Pat Fong, Xiao-Jun Wu, Jian Xiao, Bin-Kui Li, Yun Zheng, Pei-Rong Ding, Gong Chen, Miao-Zhen Qiu, Zhi-Qiang Wang, Feng-Hua Wang, Hui-Yan Luo, Feng Wang, Xiao-Zhong Wang, Ling-Yun Wang, De-Jin Xie, Tao Chen, Li-Ren Li, Zhen-Hai Lu, Xiao-Hui Zhai, Tian-Shu Liu, Ying Yuan, Jia-Qi Chen, Qiong Tan, Zhi-Zhong Pan, De-Sen Wan, Rong Zhang, Yun-Fei Yuan, Rui-Hua Xu, Yu-Hong Li
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial. PLoS medicine 21 (5) (2024)
Zi-Yao Huang, Lei Wen, Liu-Fang Ye, Yu-Ting Lu, William Pat Fong, Ren-Jing Zhang, Si-Xian Wu, Zhi-Gang Chen, Yan-Yu Cai, Rui-Hua Xu, Yu-Hong Li, Zi-Ming Du, De-Sheng Wang
Clinical and molecular characteristics of RNF43 mutations as promising prognostic biomarkers in colorectal cancer. Therapeutic advances in medical oncology 16 (2024)
Zhi-Gang Chen, Xiao-Meng Ji, Yu-Xia Xu, William Pat Fong, Xiao-Yun Liu, Jie-Ying Liang, Qiong Tan, Lei Wen, Yan-Yu Cai, De-Sheng Wang, Yu-Hong Li
Methylated ctDNA predicts early recurrence risk in patients undergoing resection of initially unresectable colorectal cancer liver metastases. Therapeutic advances in medical oncology 16 (2024)
De-Sheng Wang, Chao Ren, Shan-Shan Li, William Pat Fong, Xiao-Jun Wu, Jian Xiao, Bin-Kui Li, Yun Zheng, Pei-Rong Ding, Gong Chen, Miao-Zhen Qiu, Zhi-Qiang Wang, Feng-Hua Wang, Hui-Yan Luo, Feng Wang, Xiao-Zhong Wang, Ling-Yun Wang, De-Jin Xie, Tao Chen, Li-Ren Li, Zhen-Hai Lu, Xiao-Hui Zhai, Tian-Shu Liu, Ying Yuan, Jia-Qi Chen, Qiong Tan, Zhi-Zhong Pan, De-Sen Wan, Rong Zhang, Yun-Fei Yuan, Rui-Hua Xu, Yu-Hong Li
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial. PLoS medicine 21 (5) (2024)
Zi-Yao Huang, Lei Wen, Liu-Fang Ye, Yu-Ting Lu, William Pat Fong, Ren-Jing Zhang, Si-Xian Wu, Zhi-Gang Chen, Yan-Yu Cai, Rui-Hua Xu, Yu-Hong Li, Zi-Ming Du, De-Sheng Wang
Clinical and molecular characteristics of RNF43 mutations as promising prognostic biomarkers in colorectal cancer. Therapeutic advances in medical oncology 16 (2024)
Renjing Zhang, Yang Yang, Chunfang Hu, Mayan Huang, Wenjian Cen, Dongyi Ling, Yakang Long, Xin-Hua Yang, Boheng Xu, Junling Peng, Sujie Wang, Weijie Zhu, Mingbiao Wei, Jiaojiao Yang, Yuxia Xu, Xu Zhang, Jiangjun Ma, Fang Wang, Hongtu Zhang, Peiqing Ma, Xiaojun Zhu, Guohui Song, Li-Yue Sun, De-Sheng Wang, Feng-Hua Wang, Yu-Hong Li, Sandro Santagata, Qin Li, Yan-Fen Feng, Zi-Ming Du
Comprehensive analysis reveals potential therapeutic targets and an integrated risk stratification model for solitary fibrous tumors. Nature communications 14 (1) (2023)
Jia Liu, Ze-Xian Liu, Jia-Jun Li, Zhao-Lei Zeng, Jin-Hong Wang, Xiao-Jing Luo, Chau-Wei Wong, Jia Bo Zheng, Heng-Ying Pu, Hai-Yu Mo, Hui Sheng, Qi-Nian Wu, Hao Li, Gang Wan, Bo Li, De-Sheng Wang, Rui-Hua Xu, Huai-Qiang Ju
The macrophage-associated lncRNA MALR facilitates ILF3 liquid-liquid phase separation to promote HIF1α signaling in esophageal cancer. Cancer research (2022)
Wei Wang, Liu-Fang Ye, Hua Bao, Ming-Tao Hu, Ming Han, Hai-Meng Tang, Chao Ren, Xue Wu, Yang Shao, Feng-Hua Wang, Zhi-Wei Zhou, Yu-Hong Li, Rui-Hua Xu, De-Sheng Wang
Heterogeneity and evolution of tumour immune microenvironment in metastatic gastroesophageal adenocarcinoma. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 25 (6) (2022)
Ting Li, Yue-Tao Tan, Yan-Xing Chen, Xiao-Jun Zheng, Wen Wang, Kun Liao, Hai-Yu Mo, Junzhong Lin, Wei Yang, Hai-Long Piao, De-Sheng Wang, Huai-Qiang Ju
Methionine deficiency facilitates antitumour immunity by altering m 6 A methylation of immune checkpoint transcripts. Gut (2022)
Lei Wen, Zhigang Chen, Xiaomeng Ji, William Pat Fong, Qiong Shao, Chao Ren, Yanyu Cai, Binkui Li, Yunfei Yuan, De-Sheng Wang, Yu-Hong Li
Pathological complete response to immune checkpoint inhibitor in patients with colorectal cancer liver metastases harboring POLE exonuclease domain mutation. Journal for immunotherapy of cancer 10 (7) (2022)
Xiao-Li Wei, Fu-Rong Liu, Ji-Hong Liu, Hong-Yun Zhao, Yang Zhang, Zhi-Qiang Wang, Miao-Zheng Qiu, Fei Xu, Qiu-Qiong Yu, Yi-Wu Du, Yan-Xia Shi, De-Sheng Wang, Feng-Hua Wang, Rui-Hua Xu
First-in-human phase Ia study of the PI3Kα inhibitor CYH33 in patients with solid tumors. Nature communications 13 (1) (2022)
Liu-Fang Ye, Xiao-Meng Ji, Chao Ren, Zhi-Qiang Wang, Chun-Ping Lin, Dong-Liang Chen, Yan-Qing Cai, Ying Jin, Miao-Zheng Qiu, Zi-Ming Du, Shao-Yan Xi, Dong-Sheng Zhang, Feng Wang, Feng-Hua Wang, Rui-Hua Xu, Yu-Hong Li, De-Sheng Wang
The Prognostic Value of Locoregional Interventions for BRAF V600E Metastatic Colorectal Cancer: A Retrospective Cohort Analysis. Biomolecules 11 (9) (2021)
Yun Wang, Xiuxing Chen, Haocheng Lin, Xiaoqiang Sun, William Pat Fong, Xiao-Jun Wu, Zhizhong Pan, Yunfei Yuan, Jieying Liang, De-Sheng Wang, Ziming Du, Baocai Xing, Yuhong Li
A Prehepatectomy Circulating Exosomal microRNA Signature Predicts the Prognosis and Adjuvant Chemotherapeutic Benefits in Colorectal Liver Metastasis. Cancers 13 (17) (2021)
Xiao-Li Wei, Jian-Ying Xu, De-Sheng Wang, Dong-Liang Chen, Chao Ren, Jia-Ning Li, Feng Wang, Feng-Hua Wang, Rui-Hua Xu
Baseline lesion number as an efficacy predictive and independent prognostic factor and its joint utility with TMB for PD-1 inhibitor treatment in advanced gastric cancer. Therapeutic advances in medical oncology 13 (2021)
Long Bai, Ze-Yu Lin, Yun-Xin Lu, Qin Chen, Han Zhou, Qi Meng, Chun-Ping Lin, Wan-Lan Huang, Yun-Le Wan, Zhi-Zhong Pan, De-Sheng Wang
The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study. Cancer medicine 10 (22) (2021)
Liu-Fang Ye, Chao Ren, Long Bai, Jie-Ying Liang, Ming-Tao Hu, Hui Yang, Zhi-Qiang Wang, Feng-Hua Wang, Rui-Hua Xu, Yu-Hong Li, De-Sheng Wang
Efficacy and safety of modified FOLFIRINOX as salvage therapy for patients with refractory advanced biliary tract cancer: a retrospective study. Investigational new drugs 39 (3) (2021)
Jie-Ying Liang, Hao-Cheng Lin, Jingwen Liu, De-Sheng Wang, Yun-Fei Yuan, Bin-Kui Li, Yun Zheng, Xiao-Jun Wu, Gong Chen, Feng-Hua Wang, Zhi-Qiang Wang, Zhi-Zhong Pan, De-Sen Wan, Rui-Hua Xu, Yu-Hong Li
A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy. Cancer medicine 10 (5) (2021)
De-Sheng Wang, Zhi-Qiang Wang, Gong Chen, Jie-Wen Peng, Wei Wang, Yan-Hong Deng, Feng-Hua Wang, Jian-Wei Zhang, Han-Lin Liang, Fen Feng, Chuan-Bo Xie, Chao Ren, Ying Jin, Si-Mei Shi, Wen-Hua Fan, Zhen-Hai Lu, Pei-Rong Ding, Feng Wang, Rui-Hua Xu, Yu-Hong Li
Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II/III colorectal cancer. Cancer medicine 9 (1) (2019)